financetom
Business
financetom
/
Business
/
Nucor's Product Margins to Remain Pressured Amid Weak Steel Plates Market, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nucor's Product Margins to Remain Pressured Amid Weak Steel Plates Market, UBS Says
Dec 12, 2024 9:32 AM

12:05 PM EST, 12/12/2024 (MT Newswires) -- Nucor's ( NUE ) product margins are likely to remain pressured, with the steel plates' market conditions to weigh on earnings and volumes continue to rise in an already weak sector, UBS Securities in a note Wednesday.

"We see limited upside in the near term," UBS said, noting the company's "weak" Q3 beat and "soft" Q4 outlook.

The investment firm also said it does not expect a strong recovery in the plate market in the near term and market challenges could extend through early 2025 amid soft infrastructure spending, delays, and cancellations.

In addition, UBS said it sees Nucor's ( NUE ) elevated capital expenditures weighing on the company's 2025 and 2026 free cash flow, while the benefits of its West Virginia project will not accrue until 2027.

UBS downgraded Nucor ( NUE ) to neutral from buy, with a lower price target of $156 from $171.

Shares of Nucor ( NUE ) were down more than 5% in recent trading.

Price: 131.40, Change: -7.04, Percent Change: -5.09

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Atlas Engineered Products Q1 Loss Widens
Atlas Engineered Products Q1 Loss Widens
May 25, 2026
10:39 AM EDT, 05/25/2026 (MT Newswires) -- Atlas Engineered Products ( APEUF ) , down 3% on last look, said on Monday that first-quarter net loss widened as revenue fell. Net loss for the quarter ended March 31, widened to $1.73 million, or $0.02 per diluted share, from a loss of $0.85 million, or $0.01 per diluted share, in the...
ImmunityBio (IBRX) Facing Lawsuit After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- HBSS
ImmunityBio (IBRX) Facing Lawsuit After FDA Flags Misleading Cancer Claims, Shares Plunge 21%, $2B Market Cap Lost -- HBSS
May 25, 2026
SAN FRANCISCO, May 25, 2026 (GLOBE NEWSWIRE) -- ImmunityBio, Inc. ( IBRX ) faces a securities class action lawsuit which seeks to represent investors who purchased or otherwise acquired ImmunityBio ( IBRX ) securities between January 19, 2026 and March 24, 2026. The lawsuit follows news that the FDA sent a warning letter to the company concerning claims made by...
WonderFi Technologies Announces CIRO Approval for Acquisition by Robinhood; WonderFi Shares up 5.9%
WonderFi Technologies Announces CIRO Approval for Acquisition by Robinhood; WonderFi Shares up 5.9%
May 25, 2026
10:31 AM EDT, 05/25/2026 (MT Newswires) -- WonderFi Technologies' ( WONDF ) wholly-owned subsidiary, Coinsquare Capital Markets Ltd (CCML), received regulatory approval from the Canadian Investment Regulatory Organization (CIRO) for Robinhood Markets, Inc's previously announced acquisition of WonderFi ( WONDF ) pursuant to a statutory plan of arrangement under the Business Corporations Act (British Columbia), the company said on Monday....
PharmaCorp Rx up 10% as Announces Pharmacy Acquisition
PharmaCorp Rx up 10% as Announces Pharmacy Acquisition
May 25, 2026
11:14 AM EDT, 05/25/2026 (MT Newswires) -- PharmaCorp Rx (PCRX.V), up 10.4% on last look, is acquiring a PharmaChoice Canada-bannered pharmacy in Morrisburg, Ontario, for $8.2 million, the company said on Monday. PharmaCorp had executed letters of intent earlier this year regarding four additional pharmacy acquisitions. The Morrisburg pharmacy is the first conversion of the LOIs into a share purchase...
Copyright 2023-2026 - www.financetom.com All Rights Reserved